Welcome to our dedicated page for Regional Health Properties news (Ticker: RHE-PA), a resource for investors and traders seeking the latest updates and insights on Regional Health Properties stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Regional Health Properties's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Regional Health Properties's position in the market.
On February 17, 2023, Regional Health Properties, Inc. (RHE) announced the declaration of a dividend of one one-thousandth of a share of its Series E Redeemable Preferred Shares for each outstanding share of common stock. This dividend is payable on February 28, 2023, to shareholders of record by 5 p.m. Eastern Time on February 27, 2023. The Series E Preferred Stock will have significant voting rights, allowing 1,000,000 votes per share concerning specific amendments to the Company’s Articles of Incorporation. Additionally, unredeemed shares at a shareholder meeting will automatically be redeemed by the Company. More details will follow in a Form 8-K filing with the SEC.
Regional Health Properties, Inc. (NYSE American: RHE, RHE-PA) announced on January 3, 2023, that it received a notice from NYSE American for failing to hold an annual shareholders' meeting by December 31, 2022. The Company plans to hold the delayed 2022 annual meeting on February 14, 2023, in Duluth, Georgia. Post-meeting, Regional expects to regain compliance with NYSE listing standards. The press release also includes forward-looking statements regarding the timing of the meeting and associated expectations.
Regional Health Properties, Inc. (AMEX: RHE, RHE-PA) held a special meeting on July 25, 2022, to discuss several proposals regarding its Series A and Series B Preferred Stocks. The Preferred Series A Charter Amendment and Series B Preferred Stock proposals were approved, while the Common Charter Amendment proposal was rejected, preventing the implementation of the amendments. Additionally, the Company terminated its Exchange Offer for Series A Preferred Stock due to the lack of requisite shareholder approval, leaving the Series A Preferred Stock unchanged and outstanding.
ISS has recommended that Regional Health Properties' common shareholders vote in favor of Proposals 1 and 2 at the Special Meeting on July 25, 2022. Proposal 1 aims to amend the Series A Preferred Stock terms and increase the number of authorized shares from 60 million to 61 million, providing advantages like reducing liquidation preferences and deferring dividend accumulation. Proposal 2 seeks to approve adjournments for additional votes if necessary. The board emphasizes voting to benefit capital raising and strategic initiatives.
Regional Health Properties, Inc. (NYSE American: RHE, RHE-PA) convened a Special Meeting on
Regional Health Properties, Inc. (AMEX: RHE, RHE-PA) announced noncompliance with NYSE American's listing standards after failing to file its Q1 2022 report on time. The notice was received on May 24, 2022, stating that the delayed filing was required by May 23, 2022. The company is currently working on completing the report and plans to file it within 30 days. If not rectified, the company may face delisting procedures. The company's stock will continue to trade under symbols ‘RHE’ and ‘RHE-PA’ but will be marked as a late filer.
Regional Health Properties, Inc. (NYSE American: RHE, RHE-PA) held a Special Meeting on May 2, 2022, for holders of its 10.875% Series A Cumulative Redeemable Preferred Shares and common stock. The meeting was adjourned to May 31, 2022, to solicit additional votes. An Exchange Offer for the Series A Preferred Stock has been initiated, extending the tender deadline to the same date. As of May 2, 2022, 2,275,300 shares had been tendered, demonstrating shareholder participation.
Regional Health Properties (RHE) announced the adjournment of its Special Meeting for shareholders of its 10.875% Series A Cumulative Redeemable Preferred Shares and Common Stock, initially held on March 28, 2022, to solicit additional votes. The meeting will be reconvened on May 2, 2022. Additionally, the company is extending the expiration date of its Exchange Offer for Series A Preferred Stock to May 2, 2022. As of March 28, 2022, 1,945,379 shares of Series A Preferred Stock had been tendered in the Exchange Offer.
Regional Health Properties, Inc. (NYSE American: RHE, RHE-PA) reported financial results for the year ending December 31, 2021. The company collected 94.1% of fourth-quarter cash rent and experienced total patient care revenues of $2.0 million for Q4, totaling $9.5 million for the year. Occupancy rates stood at 65.1% amid pandemic challenges. The exchange offer for Series A Preferred Shares aims to streamline capital structure. Net loss attributable to common stockholders was $661,000 for Q4, less than $1.0 million a year prior, with cash increasing to $6.8 million.
Regional Health Properties, Inc. (NYSE American: RHE, RHE-PA) has announced an Exchange Offer for its outstanding 10.875% Series A Cumulative Redeemable Preferred Shares, proposing to exchange them for newly issued 12.5% Series B Cumulative Redeemable Preferred Shares. This offer is valid until 11:59 p.m. on March 28, 2022, unless extended. The Exchange Offer's success is contingent upon shareholder approval of associated proposals during a special meeting. The complete terms are outlined in the Proxy Statement/Prospectus filed with the SEC.
FAQ